|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/04/22 Cryoport, Inc. 10-Q 9/30/22 89:11M Toppan Merrill/FA2 |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 2.68M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 31K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
10: R1 Document and Entity Information HTML 77K
11: R2 Condensed Consolidated Balance Sheets HTML 149K
12: R3 Condensed Consolidated Balance Sheets HTML 49K
(Parenthetical)
13: R4 Condensed Consolidated Statements of Operations HTML 122K
14: R5 Condensed Consolidated Statements of Comprehensive HTML 56K
Loss
15: R6 Condensed Consolidated Statements of Stockholders' HTML 120K
Equity
16: R7 Condensed Consolidated Statements of Stockholders' HTML 27K
Equity (Parenthetical)
17: R8 Condensed Consolidated Statements of Cash Flows HTML 160K
18: R9 Condensed Consolidated Statements of Cash Flows HTML 27K
(Parenthetical)
19: R10 Management's Representation and Basis of HTML 29K
Presentation
20: R11 Nature of the Business HTML 30K
21: R12 Summary of Significant Accounting Policies HTML 185K
22: R13 Acquisitions HTML 32K
23: R14 Cash, Cash Equivalents and Short-Term Investments HTML 126K
24: R15 Fair Value Measurements HTML 107K
25: R16 Inventory HTML 39K
26: R17 Goodwill and Intangible Assets HTML 136K
27: R18 Convertible Senior Notes HTML 87K
28: R19 Notes Payable HTML 72K
29: R20 Leases HTML 106K
30: R21 Commitments and Contingencies HTML 34K
31: R22 Stockholders' Equity HTML 58K
32: R23 Stock-Based Compensation HTML 113K
33: R24 Summary of Significant Accounting Policies HTML 257K
(Policies)
34: R25 Summary of Significant Accounting Policies HTML 129K
(Tables)
35: R26 Cash, Cash Equivalents and Short-Term Investments HTML 128K
(Tables)
36: R27 Fair Value Measurements (Tables) HTML 103K
37: R28 Inventory (Tables) HTML 40K
38: R29 Goodwill and Intangible Assets (Tables) HTML 142K
39: R30 Convertible Senior Notes (Tables) HTML 60K
40: R31 Notes Payable (Tables) HTML 74K
41: R32 Leases (Tables) HTML 109K
42: R33 Stockholders' Equity (Tables) HTML 32K
43: R34 Stock-Based Compensation (Tables) HTML 114K
44: R35 Summary of Significant Accounting Policies - HTML 41K
Disaggregates Our Revenues by Major Source
(Details)
45: R36 Summary of Significant Accounting Policies - HTML 41K
Disaggregation Our Geographical Revenues by Origin
(Details)
46: R37 Summary of Significant Accounting Policies - HTML 63K
Earnings Per Share (Details)
47: R38 Summary of Significant Accounting Policies - HTML 42K
Antidilutive Shares (Details)
48: R39 Summary of Significant Accounting Policies - HTML 138K
Additional Information (Details)
49: R40 Acquisition - Additional Information (Details) HTML 72K
50: R41 Cash, Cash Equivalents and Short-Term Investments HTML 51K
(Details)
51: R42 Cash, Cash Equivalents and Short-Term Investments HTML 38K
- Available-for-sale Investments (Details)
52: R43 Cash, Cash Equivalents and Short-Term Investments HTML 46K
- Contractual Maturities (Details)
53: R44 Cash, Cash Equivalents and Short-Term Investments HTML 30K
- Equity Investments (Details)
54: R45 Cash, Cash Equivalents and Short-Term Investments HTML 30K
- Additional Information (Details)
55: R46 Fair Value Measurements (Details) HTML 43K
56: R47 Fair Value Measurements - Additional Information HTML 26K
(Details)
57: R48 Fair Value Measurements - Estimated fair values HTML 34K
and the carrying values (Details)
58: R49 Inventory (Details) HTML 33K
59: R50 Goodwill and Intangible Assets - Schedule of HTML 45K
goodwill (Details)
60: R51 Goodwill and Intangible Assets - Intangible Assets HTML 59K
(Details)
61: R52 Goodwill and Intangible Assets - Expected Future HTML 40K
Amortization (Details)
62: R53 Goodwill and Intangible Assets - Additional HTML 28K
Information (Details)
63: R54 Convertible Senior Notes - Components of HTML 37K
Convertible notes payable (Details)
64: R55 Convertible Senior Notes - Interest expenses HTML 34K
incurred on Convertible notes payable (Details)
65: R56 Convertible Senior Notes - Additional information HTML 111K
(Details)
66: R57 Notes Payable (Details) HTML 47K
67: R58 Notes Payable - Interest expense (Details) HTML 37K
68: R59 Note Payable - CRYOPDP Note (Details) HTML 40K
69: R60 Notes Payable - Cell&Co Notes (Details) HTML 36K
70: R61 Notes Payable - Future note payments (Details) HTML 51K
71: R62 Leases - Components Of Lease Cost (Details) HTML 37K
72: R63 Leases - Supplemental Cash Flows Information HTML 52K
(Details)
73: R64 Leases - Future Payments Under Non-Cancellable HTML 73K
Leases (Details)
74: R65 Leases - Additional Information (Details) HTML 32K
75: R66 Commitments and Contingencies (Details) HTML 37K
76: R67 Stockholders' Equity - Common Stock Reserved for HTML 40K
Future Issuance (Details)
77: R68 Stockholders' Equity - Repurchase Program HTML 34K
(Details)
78: R69 Stockholders' Equity - November 2021 Registered HTML 41K
Direct Placement and Stock Purchase Agreements
(Details)
79: R70 Stockholders' Equity - Additional Information HTML 148K
(Details)
80: R71 Stock-Based Compensation - Assumptions Used to HTML 43K
Estimate Fair Value of Stock Options (Details)
81: R72 Stock-Based Compensation - Stock-based HTML 35K
Compensation Expense (Details)
82: R73 Stock-Based Compensation - Stock Option Activity HTML 82K
(Details)
83: R74 Stock-Based Compensation - Restricted stock unit HTML 48K
(Details)
84: R75 Stock-Based Compensation - Additional Information HTML 62K
(Details)
87: XML IDEA XML File -- Filing Summary XML 166K
85: XML XBRL Instance -- cyrx-20220930x10q_htm XML 3.04M
86: EXCEL IDEA Workbook of Financial Reports XLSX 191K
6: EX-101.CAL XBRL Calculations -- cyrx-20220930_cal XML 231K
7: EX-101.DEF XBRL Definitions -- cyrx-20220930_def XML 812K
8: EX-101.LAB XBRL Labels -- cyrx-20220930_lab XML 1.68M
9: EX-101.PRE XBRL Presentations -- cyrx-20220930_pre XML 1.21M
5: EX-101.SCH XBRL Schema -- cyrx-20220930 XSD 222K
88: JSON XBRL Instance as JSON Data -- MetaLinks 489± 767K
89: ZIP XBRL Zipped Folder -- 0001410578-22-002947-xbrl Zip 464K
EXHIBIT 31.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Jerrell W. Shelton, certify that:
1. | I have reviewed this quarterly report on Form 10-Q of Cryoport, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 4, 2022
| |
| |
| |
President and Chief Executive Officer | |
(Principal Executive Officer) | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/4/22 | None on these Dates | ||
| For Period end: | 9/30/22 | |||
| List all Filings | ||||